Overall, 21 CML patients showed 12 BCR-ABL gene mutations (6 novel and 6 reported) and these mutated BCR-ABL protein sequences were submitted independently to the SIFT program to check their tolerance. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.